4-(4-(3-ETHYL-2(3H)-BENZOXAZOLYLIDENE)-2-BUTENYLIDENE)-3-METHYL-1-P-SULFOPHENYL-2-PYRAZOLIN-5-ONE
UNII 5G3PPG6Z2P
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(4-(3-ethyl-2(3h)-benzoxazolylidene)-2-butenylidene)-3-methyl-1-p-sulfophenyl-2-pyrazolin-5-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5G3PPG6Z2P.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 29637-29-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H21N3O5S ORAPKIMSYPKJRA-SBVKBHTESA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(4-(3-ethyl-2(3h)-benzoxazolylidene)-2-butenylidene)-3-methyl-1-p-sulfophenyl-2-pyrazolin-5-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.